Cargando…
Real-world Effectiveness of Ledipasvir/Sofosbuvir (LDV/SOF) for 8 weeks in Patients Coinfected with HCV and HIV-1
BACKGROUND: Real world cohorts (RWC) have demonstrated excellent efficacy of LDV/SOF for 8 weeks in HCV monoinfected patients. Real world effectiveness data of LDV/SOF for 8 weeks in HIV/HCV coinfection is emerging from several multiple single-center and multicenter prospective and retrospective coh...
Autores principales: | Ruane, Peter, Buggisch, Peter, Moreno, ANA, Isakov, Vasily, Backus, Lisa, Ain, Dani, Gonzalez-Garcia, Juan, Naik, Sarjita, Mehta, Swarup, Lee, Jina, Llewellyn, Joe, Mertens, Michael, Natha, Macky, Osinusi, Anu, Slim, Jihad, Zhdanov, Konstantin, Berenguer, Juan, Zeuzem, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630989/ http://dx.doi.org/10.1093/ofid/ofx163.1752 |
Ejemplares similares
-
Sofosbuvir (SOF) Suppresses Ledipasvir (LDV)-resistant Mutants during SOF/LDV Combination Therapy against Genotype 1b Hepatitis C Virus (HCV)
por: Brown, Ashley N., et al.
Publicado: (2017) -
The levels of monoamine neurotransmitters and measures of mental and emotional health in HCV patients treated with ledipasvir (LDV) and sofosbuvir (SOF) with or without ribavirin (RBV)
por: Golabi, Pegah, et al.
Publicado: (2016) -
Real-world effectiveness and safety of sofosbuvir/velpatasvir and ledipasvir/sofosbuvir hepatitis C treatment in a single centre in Germany
por: Buggisch, Peter, et al.
Publicado: (2019) -
New-Onset Diabetes Mellitus With Exposure to Ledipasvir and Sofosbuvir
por: Premji, Resmi, et al.
Publicado: (2015) -
Palisaded neutrophilic and granulomatous dermatitis associated with ledipasvir/sofosbuvir
por: Shenk, Mary Elizabeth Reed, et al.
Publicado: (2018)